NantOmics

NantOmics

NantOmics

Add article description

NantOmics is a biotechnology company based in Culver City, California, which provides molecular diagnostic products for personalized cancer treatment. It is part of the NantWorks network, a corporation consisting of different startups in the medical and health industry.[1]

Quick Facts Company type, Industry ...

History

NantOmics was founded in 2013 by billionaire Patrick Soon-Shiong. In 2015 NantOmics bought the cancer diagnostics company OncoPlex Dx.[2] In 2017 the company acquired the consumer genomics startup Genos.[3] Three years later, in 2020, NantOmics shutdown Genos.[4]

Products

GPS Cancer involves sequencing of the genome and RNA of tumor cells in comparison to normal cells from the same individual in order to develop personalized treatments.[5] About 327,000 cancer patients participated in a GPS cancer pilot project in 2017.[6]

References

  1. [1]
    "NantOmics, LLC: Private Company Information - Bloomberg". www.bloomberg.com. Retrieved 2018-03-30.[dead link]
  2. [2]
    "NantOmics Acquires OncoPlex Diagnostics, an Accredited Proteomics Diagnostic Laboratory". Retrieved 2018-03-30.
  3. [3]
    "Bio-IT World". www.bio-itworld.com. Retrieved 2018-03-30.
  4. [4]
    "NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services". genomeweb.
  5. [5]
    "GPS Cancer Overview". GPS Cancer. Retrieved 2018-03-30.
  6. [6]
    "NantHealth Reports 16% Increase in 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% and GPS Adoption Continues to Climb". Retrieved 2018-03-30.
Share this article:

This article uses material from the Wikipedia article NantOmics, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.